Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, across 1,700+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai® One is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.
External link for Viz.ai
Viz.ai One™ One Platform. Many Clinical Applications. Viz Cardio™ AI-powered cardiology workflows to detect, connect, and treat. Enhances collaboration with specialties. Viz Connect® Optimize the post-acute stroke care pathway by connecting the Brain-Heart team using integrated HIPAA-compliant collaboration tools to enhance care coordination. Viz™ Neuro Most studied and comprehensive neurovascular portfolio. Deliver prompt and efficient patient care through streamlined multidisciplinary workflows and coordination across networks. Viz Radiology™ Accelerate patient diagnosis and treatment with a suite of AI-powered tools designed to enhance the efficiency and workflow of radiologists. Viz™ Trauma Tailored for trauma care providers, this solution expedites patient care and provides the needed metrics to abide by ACS trauma standards. Viz™ Vascular Establish urgency and coordinate care with a comprehensive suite of AI-powered vascular workflow solutions
x
San Francisco, CA x, US
x
Tel Aviv, Yafo x, IL
🎤 Our VP of Clinical, Prem Batchu-Green DPT, MBA,HEOR-C was interviewed on-site at #HLTHUSA where she was asked, “how should healthcare be bridging the gaps between providers, payers, and pharma?” Watch this clip for her answer:
How do we bridge the gap between providers, payers, and pharma? Check out Prem Batchu-Green DPT, MBA,HEOR-C's information-packed interview from #HLTHUSA. ⬇️ Viz.ai HLTH Inc.
Health care investment in AI is forecast to increase from $14b in 2022 to $164b in 2029, but achieving demonstrable results faces numerous barriers. Join our CEO and co-founder Dr Chris Mansi in a panel discussion on “Artificial Intelligence in Biopharma: Managing the Learning Curve for Patients and Society” at the #PrixGalienUSA Forum in NYC on November 7 to discuss Responsible AI, predict the state of AI/ML capabilities in healthcare by 2030 and share viewpoints among stakeholders, including patients and regulators.
Another great case shared by Dr. Stiefel at Piedmont! Great to see stroke care continue to evolve and Viz.ai LVO alerts making a real impact on patient outcomes https://lnkd.in/ew9zf7Jh #TimeIsBrain #StrokeAwareness #WorldStrokeDay
Piedmont Stroke Program…Real Change Lives Here! Implemenation of technology bringing stroke care together for a 41-year-old male last known well 30 minutes prior to arriving at one of the 19 Piedmont Stroke Centers; NIHSS 18. VIZ ai for LVO alert, CT perfusion and communication among providers across hospitals nearly 50 miles away. 20 minutes from arrival to endovascular disposition. Air Methods, Air Life Georgia Flight tracker app for ETA. Flight in the air within 28 min of arrival. Trans-Radial aspiration thrombectomy of ICA with BMX 96 and Route 92 Free Climb 70 with Tenzing 7. M2 and ACA combination thrombectomy with Stryker Vecta 46 and Phenox pRESET stent-retriever Stroke care continues to evolve. Patients benefit when we all work together; people, places & technology.
On #WorldStrokeDay, we stand with dedicated clinicians worldwide in the relentless pursuit of stroke prevention, treatment, and patient care. Thank you! 🌎 🧠 💙 #TimeIsBrain #StrokeAwareness
Congratulations to our CEO and Co-founder Dr Chris Mansi, who was recently the keynote speaker at the Forbes Next Billion-Dollar Startups celebration. He shared insights with Amy Feldman on how Viz.ai was able to pioneer AI-powered care coordination, disrupt the status quo and successfully scale to more than 1,700 hospitals. Kudos to this next wave of innovators recognized by Forbes!
This year's dinner to celebrate the 10th anniversary of the Forbes Next Billion-Dollar Startups list at SHACK15 in San Francisco. Amazing views, especially for this New Yorker. A great conversation with Dr Chris Mansi, of Viz.ai (an alum of the 2021 list and now worth over $1B) about using AI in medicine. And a nice catch-up with Promise's Phaedra Ellis-Lamkins, who I'd profiled in the magazine over the summer. Great to see those who were able to be there, and big thanks to our partners at TrueBridge Capital Partners for doing all the event planning!
Viz.ai reposted this
Thrilled to be part of a thought-provoking session on hypertrophic cardiomyopathy at #HCMSummit8. From Algorithms to Outcomes, we explored the potential and challenges of #AI in improving patient outcomes. Huge thanks to our incredible speakers from Cleveland Clinic, UCSD, and HCMA for their insights and expertise — exciting to see how our collaboration is shaping the future! Viz.ai Katy Rutkowski, MSN, RN Milind Desai MD MBA JORGE SILVA ENCISO Lisa Salberg
Heading to📍San Diego 🌊 for the annual Society of NeuroInterventional Surgery (SVIN) meeting on November 20-22? Join #TeamViz at booth #105 to discover how our latest Viz Neuro Suite innovations are driving clinical and economic impact in stroke care. Schedule a meeting with us to discuss how we can continue to elevate stroke care together 👉 https://lnkd.in/eizGBjtj #SVIN24 #ForwardTogether
This content isn’t available here
Access this content and more in the LinkedIn app
Incredible success story! After implementing Viz.ai transfer times for stroke patients went from an average of 202 minutes in 2023 to just 109 minutes! ⏱️ 💡 As Dr. Kwan Ng said, "Time to treatment is brain saved." Read more here: https://lnkd.in/eM8nUn9e #StrokeCare #AIInHealthcare #StrokeInnovation #PatientCare
Our partner hospital, Adventist Health and Rideout (AHRO) has dramatically cut the time it takes to transfer stroke patients to specialty care thanks to a new artificial intelligence tool called Viz.ai. As a result, AHRO’s stroke program reduced what’s known as door-in-door-out time from an average of 202 minutes in 2023 to 109 minutes now. When a potential stroke patient arrives at AHRO, their CT scan is uploaded to the secure Viz.ai platform. Within minutes, the AI analyzes the scan. If it identifies a large vessel occlusion, a major type of stroke, the tool sends mobile notifications to vascular neurologists at both AHRO and our Comprehensive Stroke Center. Reviewing physicians decide whether or not the patient should transfer to UC Davis Health for more specialized care. "Being able to connect stroke experts at UC Davis Health with ED providers at Rideout rapidly improves access to life-changing treatments and outcomes for stroke patients. Time to treatment is brain saved," said Kwan Ng, director of our Comprehensive Stroke Center. Learn more: https://lnkd.in/gys2xPug
🙌 We are proud to announce that Viz.ai One™️ is a finalist in the 2024 Pharmaceutical Executive APEX Awards—the only awards show judged entirely by healthcare professionals and the patients they treat. We are excited that our brand campaign is receiving this recognition and look forward to the winner's announcement on November 13. #PEAPEXAwards https://lnkd.in/eHs3P4xk
Tom Krohn, VP, Global Pharma Commercial Lead Viz.ai, moderated a discussion on omnichannel reach and new channels to strengthen the HCP journey with an expert panel to kick off day 1 of Reuters Pharma Customer Engagement USA! #REcustomerUSA AI at the point of care has demonstrated real-world results, helping HCPs get patients to the right diagnosis, specialist, follow-up care, and treatment—faster. It's an exciting time for Pharma brands and patient care. Thank you to Reuters Events Pharma and the panelists: Amir Golan (Novartis), Prem Schoff (Novo Nordisk), Christina Kotsi (Bayer) and Bryan Hancsin (Genmab) #CareCoordination #AIinHealthcare #Omnichannel https://lnkd.in/eAQ-7qSw
A line up of #omnichannel experts wrapping up Day 1 of Reuters Pharma Customer Engagement USA! Thank you to our panel for insights on how we can pinpoint omnichannel reach and impact, and leverage new channels to strengthen customer journeys. Amir Golan (Novartis), Prem Schoff (Novo Nordisk), Tom Krohn (Viz.ai), Christina Kotsi (Bayer) and Bryan Hancsin (Genmab) #REcustomerUSA